Geopolitics Alpha

McKesson Stock: The Biggest Drug Wholesaler Just Crushed Earnings Views — Here's What To Know

Published . Updated .

Key takeaways

  • McKesson stock was flat late Wednesday, though the drug wholesaler topped fiscal second-quarter views and hiked its earnings guide.
  • Exposed: MRK, XLV, XBI, LLY, JNJ
  • Market reaction: price tracking starts with the next trading session.

Market Call

Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.

Get these market calls by email

The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.

Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.

McKesson Stock: The Biggest Drug Wholesaler Just Crushed Earnings Views — Here's What To Know

McKesson stock was flat late Wednesday, though the drug wholesaler topped fiscal second-quarter views and hiked its earnings guide.

Directly affected

  • MCK Mckesson+8.5% 30d

    Named in this report.

Indirectly affected

  • XLV Health Care Select Sector SPDR

    Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “drug” (pharma and health) in this story.

  • XBI SPDR S&P Biotech ETF

    SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “drug” (pharma and health) in this story.

  • LLY Eli Lilly and+22.4% 30d

    Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “drug” (pharma and health) in this story.

  • JNJ Johnson & Johnson-1.7% 30d

    Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “drug” (pharma and health) in this story.

  • PFE Pfizer+5.5% 30d

    Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “drug” (pharma and health) in this story.

  • MRK Merck+1.9% 18d

    Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “drug” (pharma and health) in this story.

Price reaction, T-5 to T+3

TickerT-5T-3T-1T0T+1T+2T+3
MCK-8.19%-6.55%baseafter closeafter closeafter closeafter close
XLV-2.96%-2.66%baseafter closeafter closeafter closeafter close
XBI-0.81%-4.43%baseafter closeafter closeafter closeafter close
LLY-3.15%-0.45%baseafter closeafter closeafter closeafter close
JNJ-0.43%-2.09%baseafter closeafter closeafter closeafter close
PFE-2.73%-0.26%baseafter closeafter closeafter closeafter close
MRK-2.69%-1.28%baseafter closeafter closeafter closeafter close

Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.

McKesson Stock: The Biggest Drug Wholesaler Just Crushed Earnings Views — Here's What To Know Investor's Business Daily

Source: Investor's Business Daily

The price since 4 Nov 2026: Merck (MRK) versus the S&P 500

CompanyWhenMoveStatus
Johnson & Johnson (JNJ)three days earlier-2.09%final price
Johnson & Johnson (JNJ)five days earlier-0.43%final price
Eli Lilly (LLY)three days earlier-0.45%final price
Eli Lilly (LLY)five days earlier-3.15%final price
MCKthree days earlier-6.55%final price
MCKfive days earlier-8.19%final price
Merck (MRK)three days earlier-1.28%final price
Merck (MRK)five days earlier-2.69%final price
Pfizer (PFE)three days earlier-0.26%final price
Pfizer (PFE)five days earlier-2.73%final price
Spdr Series Trust (XBI)three days earlier-4.43%final price
Spdr Series Trust (XBI)five days earlier-0.81%final price
Select Sector Spdr Tr (XLV)three days earlier-2.66%final price
Select Sector Spdr Tr (XLV)five days earlier-2.96%final price

Trades by members of Congress and officials in the stocks in this story

Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).

Who gains and who loses around Merck (MRK)

Companies carried with this story

  • MRK Merck

    In “McKesson Stock: The Biggest Drug Wholesaler Just Crushed Earnings Views — Here's What To Know,” Merck (MRK) is linked, with no stored direction, medium confidence. Reason on file: Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “drug” (pharma and health) in this story

  • XLV Select Sector Spdr Tr

    Select Sector Spdr Tr (XLV) is linked, with no stored direction, medium confidence in the 4 Nov 2026 story “McKesson Stock: The Biggest Drug Wholesaler Just Crushed Earnings Views — Here's What To Know.” Reason on file: Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “drug” (pharma and health) in this story

  • XBI Spdr Series Trust

    Spdr Series Trust (XBI) is linked, with no stored direction, medium confidence in the 4 Nov 2026 story “McKesson Stock: The Biggest Drug Wholesaler Just Crushed Earnings Views — Here's What To Know.” Reason on file: SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “drug” (pharma and health) in this story

  • LLY Eli Lilly

    For “McKesson Stock: The Biggest Drug Wholesaler Just Crushed Earnings Views — Here's What To Know,” Eli Lilly (LLY) is linked, with no stored direction, medium confidence. Reason on file: Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “drug” (pharma and health) in this story

  • JNJ Johnson & Johnson

    For “McKesson Stock: The Biggest Drug Wholesaler Just Crushed Earnings Views — Here's What To Know,” Johnson & Johnson (JNJ) is linked, with no stored direction, medium confidence. Reason on file: Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “drug” (pharma and health) in this story

  • PFE Pfizer

    Pfizer (PFE) is linked, with no stored direction, medium confidence in the 4 Nov 2026 story “McKesson Stock: The Biggest Drug Wholesaler Just Crushed Earnings Views — Here's What To Know.” Reason on file: Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “drug” (pharma and health) in this story

Merck (MRK)

On 4 Nov 2026, “McKesson Stock: The Biggest Drug Wholesaler Just Crushed Earnings Views — Here's What To Know” is the story that connects Merck (MRK) to this story.

The link for Merck (MRK) is this: Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “drug” (pharma and health) in this story

Also listed, Select Sector Spdr Tr (XLV): Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “drug” (pharma and health) in this story

Dates and price levels for Merck (MRK)

MRK traded between 139.39 and 154.04 across 18 sessions. The latest close on file is 144.68.

How strong the case is around Merck (MRK)

46 out of 100

“McKesson Stock: The Biggest Drug Wholesaler Just Crushed Earnings Views — Here's What To Know” scores 46 out of 100. The score uses 1 sources, and 6 linked companies.